{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:58:33Z","timestamp":1794707913302,"version":"4.9.1"},"reference-count":100,"publisher":"American Society of Hematology","issue":"5","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,29]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The BCR::ABL1 tyrosine kinase inhibitors (TKI) in chronic myeloid leukemia (CML) represent a paradigm for molecularly targeted therapy. However, clinical outcomes (rate\/depth of response, treatment-free remission [TFR], progression to blast crisis [BC]) and adverse events vary among patients. While additional somatic mutations have been invoked to explain varying clinical outcomes, we here propose a complementary perspective based on single-cell omics (sc-omics) approaches that have enabled unprecedented resolution of the cellular ecosystems, including their composition, interactions, and activity. In patients who were treatment-na\u00efve and in chronic phase (CP), this has revealed differences in the growth-rate of BCR::ABL1+ clones, ratio of TKI-insensitive leukemic stem cells (LSC) to residual hematopoietic stem cells (HSC), and immune cell composition, factors that collectively contribute to variability in therapy efficacy. Together these findings suggest that cellular heterogeneity serves as a foundation of clinical outcome in CML. Patients who remain in CP exhibit an erythroid signature in LSC, while those progressing to BC manifest an inflammatory profile, additional mutations, and expansion of early progenitors. Deep responders with active natural killer, and regulatory T cells are more likely to sustain TFR. Similarly, the outcomes of donor lymphocyte infusion after allogeneic stem cell transplant are heterogeneous, and reflect differences in preexisting T-cell clonotypes, their expansion, and interaction with leukemic cells in responders vs nonresponders. Here, we summarize key insights from sc-omics in CML, and propose an actionable road map to further leverage these technologies. This includes mechanistically explaining heterogeneity, predicting therapy response and BC, tracking leukemogenic clones longitudinally, targeting TKI-insensitive LSC, and restoring hematopoiesis from residual HSCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025029011","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:01:12Z","timestamp":1760731272000},"page":"485-496","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Insights from single-cell omics: cellular heterogeneity as a foundation of clinical outcome in chronic myeloid leukemia"],"prefix":"10.1182","volume":"147","author":[{"given":"Ram Krishna","family":"Thakur","sequence":"first","affiliation":[{"name":"Division of Molecular Hematology, Lund Stem Cell Center, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-754X","authenticated-orcid":false,"given":"G\u00f6ran","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Division of Molecular Hematology, Lund Stem Cell Center, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10314","key":"2026012911212142800_bib1","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0140-6736(21)01204-6","article-title":"Chronic myeloid leukaemia","volume":"398","author":"Cortes","year":"2021","journal-title":"Lancet"},{"issue":"18","key":"2026012911212142800_bib2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/jama.2025.0220","article-title":"Chronic myeloid leukemia: a review","volume":"333","author":"Jabbour","year":"2025","journal-title":"JAMA"},{"issue":"suppl 1","key":"2026012911212142800_bib3","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/blood-2023-178703","article-title":"Tyrosine kinase inhibitor (TKI) treatment patterns in 5,261 chronic phase (CP) chronic myeloid leukemia (CML) patients in \u201creal-life\u201d settings: a population-based study using a nationwide claim database","volume":"142","author":"Benmerad","year":"2023","journal-title":"Blood"},{"issue":"8","key":"2026012911212142800_bib4","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41375-019-0512-y","article-title":"Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia","volume":"33","author":"Branford","year":"2019","journal-title":"Leukemia"},{"issue":"4","key":"2026012911212142800_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and resistance to BCR-ABL1-targeted therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"2026012911212142800_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41576-020-0265-5","article-title":"Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics","volume":"22","author":"Nam","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"12","key":"2026012911212142800_bib7","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/leu.2014.272","article-title":"Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status","volume":"28","author":"Schmidt","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"2026012911212142800_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2014.10.036","article-title":"Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation","volume":"9","author":"Ugale","year":"2014","journal-title":"Cell Rep"},{"issue":"5","key":"2026012911212142800_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"2026012911212142800_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","article-title":"MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors","volume":"6","author":"Huntly","year":"2004","journal-title":"Cancer Cell"},{"issue":"5","key":"2026012911212142800_bib11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41375-025-02606-6","article-title":"Prognostic scoring systems in chronic myeloid leukaemia","volume":"39","author":"Lauseker","year":"2025","journal-title":"Leukemia"},{"issue":"1","key":"2026012911212142800_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.leu.2402329","article-title":"Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases","volume":"16","author":"Schoch","year":"2002","journal-title":"Leukemia"},{"issue":"1","key":"2026012911212142800_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2141.1997.9662656.x","article-title":"Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques","volume":"97","author":"Haferlach","year":"1997","journal-title":"Br J Haematol"},{"issue":"10","key":"2026012911212142800_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2026012911212142800_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-08-303495","article-title":"Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib","volume":"119","author":"Kumari","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2026012911212142800_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"2026012911212142800_bib17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2026012911212142800_bib18","first-page":"2738","article-title":"A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia","volume":"141","author":"Krishnan","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2026012911212142800_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.4336","article-title":"Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia","volume":"23","author":"Giustacchini","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"2026012911212142800_bib20","doi-asserted-by":"crossref","first-page":"lqae047","DOI":"10.1093\/nargab\/lqae047","article-title":"Advances in single-cell long-read sequencing technologies","volume":"6","author":"Gupta","year":"2024","journal-title":"NAR Genom Bioinform"},{"issue":"8","key":"2026012911212142800_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","article-title":"Best practices for single-cell analysis across modalities","volume":"24","author":"Heumos","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2026012911212142800_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41467-022-28661-6","article-title":"Single-cell gene fusion detection by scFusion","volume":"13","author":"Jin","year":"2022","journal-title":"Nat Commun"},{"key":"2026012911212142800_bib23","doi-asserted-by":"crossref","first-page":"RP92074","DOI":"10.7554\/eLife.92074.3","article-title":"Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response","volume":"12","author":"Warfvinge","year":"2024","journal-title":"Elife"},{"key":"2026012911212142800_bib24","doi-asserted-by":"crossref","first-page":"e27041","DOI":"10.7554\/eLife.27041","article-title":"The human cell atlas","volume":"6","author":"Regev","year":"2017","journal-title":"Elife"},{"key":"2026012911212142800_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40880-016-0108-0","article-title":"The Philadelphia chromosome in leukemogenesis","volume":"35","author":"Kang","year":"2016","journal-title":"Chin J Cancer"},{"issue":"suppl 1","key":"2026012911212142800_bib26","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1182\/blood-2023-182454","article-title":"Multiomic single-cell sequencing may distinguish BCR-ABL-mutated acute myeloid leukemia (AML) from blast crisis chronic myelogenous leukemia (BC-CML)","volume":"142","author":"Kennedy","year":"2023","journal-title":"Blood"},{"issue":"8060","key":"2026012911212142800_bib27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41586-025-08817-2","article-title":"Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia","volume":"640","author":"Kamizela","year":"2025","journal-title":"Nature"},{"issue":"3","key":"2026012911212142800_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1667\/RR2892.1","article-title":"The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001","volume":"179","author":"Hsu","year":"2013","journal-title":"Radiat Res"},{"issue":"19","key":"2026012911212142800_bib29","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1182\/blood-2011-09-381855","article-title":"Quantitative modeling of chronic myeloid leukemia: insights from radiobiology","volume":"119","author":"Radivoyevitch","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2026012911212142800_bib30","doi-asserted-by":"crossref","first-page":"e1010677","DOI":"10.1371\/journal.pcbi.1010677","article-title":"Inferring parameters of cancer evolution in chronic lymphocytic leukemia","volume":"18","author":"Lee","year":"2022","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"2026012911212142800_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000501146","article-title":"Systematic review of normal subjects harbouring BCR-ABL1 fusion gene","volume":"143","author":"Kuan","year":"2020","journal-title":"Acta Haematol"},{"issue":"6","key":"2026012911212142800_bib32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.cell.2019.01.022","article-title":"Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics","volume":"176","author":"Ludwig","year":"2019","journal-title":"Cell"},{"issue":"17","key":"2026012911212142800_bib33","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1182\/blood-2016-07-728873","article-title":"Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML","volume":"129","author":"Warfvinge","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2026012911212142800_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2141.1972.tb08795.x","article-title":"Granulopoiesis in chronic granulocytic leukaemia","volume":"22","author":"Galbraith","year":"1972","journal-title":"Br J Haematol"},{"issue":"12","key":"2026012911212142800_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0145-2126(98)00113-1","article-title":"Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia","volume":"22","author":"Eaves","year":"1998","journal-title":"Leuk Res"},{"issue":"3","key":"2026012911212142800_bib36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41423-025-01259-w","article-title":"Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis","volume":"22","author":"Signoretto","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2026012911212142800_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41590-022-01189-z","article-title":"CD66b\u2212CD64dimCD115\u2212 cells in the human bone marrow represent neutrophil-committed progenitors","volume":"23","author":"Calzetti","year":"2022","journal-title":"Nat Immunol"},{"issue":"1","key":"2026012911212142800_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41375-022-01736-5","article-title":"Pathogenesis and management of accelerated and blast phases of chronic myeloid leukemia","volume":"37","author":"Senapati","year":"2023","journal-title":"Leukemia"},{"issue":"7","key":"2026012911212142800_bib39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"2026012911212142800_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/bloodadvances.2016000810","article-title":"Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia","volume":"1","author":"Kinstrie","year":"2016","journal-title":"Blood Adv"},{"issue":"7","key":"2026012911212142800_bib41","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: mechanisms of blastic transformation","volume":"120","author":"Perrotti","year":"2010","journal-title":"J Clin Invest"},{"key":"2026012911212142800_bib42","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.09.632094","article-title":"Single-cell transcriptomics-guided development of flow cytometric tests predicting chronic myeloid leukemia blast crisis transformation at chronic phase diagnosis","author":"Yu","year":"15  2025","journal-title":"bioRxiv"},{"issue":"3","key":"2026012911212142800_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","article-title":"The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML","volume":"20","author":"Vetrie","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"2026012911212142800_bib44","doi-asserted-by":"crossref","first-page":"25337","DOI":"10.18632\/aging.104136","article-title":"Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"2026012911212142800_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2022.09.001","article-title":"Ex vivo expansion of phenotypic and transcriptomic chronic myeloid leukemia stem cells","volume":"115","author":"Patel","year":"2022","journal-title":"Exp Hematol"},{"issue":"1","key":"2026012911212142800_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41467-024-44771-9","article-title":"Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease","volume":"15","author":"Scott","year":"2024","journal-title":"Nat Commun"},{"issue":"suppl 1","key":"2026012911212142800_bib47","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1182\/blood-2018-99-115387","article-title":"Characterizing population heterogeneity and signaling changes in chronic myeloid leukemia stem and progenitor cells upon combined treatment with imatinib and MEK inhibitors using quantitative single cell phospho-imaging","volume":"132","author":"Reister Schultz","year":"2018","journal-title":"Blood"},{"issue":"6","key":"2026012911212142800_bib48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1182\/blood.2022018196","article-title":"Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells","volume":"142","author":"Qiu","year":"2023","journal-title":"Blood"},{"issue":"21","key":"2026012911212142800_bib49","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1073\/pnas.1903550116","article-title":"Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cells","volume":"116","author":"Ma","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7607","key":"2026012911212142800_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"issue":"7","key":"2026012911212142800_bib51","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/leu.2013.19","article-title":"Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients","volume":"27","author":"Mustjoki","year":"2013","journal-title":"Leukemia"},{"issue":"25","key":"2026012911212142800_bib52","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198306233082502","article-title":"Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia","volume":"308","author":"Coulombel","year":"1983","journal-title":"N Engl J Med"},{"key":"2026012911212142800_bib53","article-title":"Single-cell multiomics reveals distinct cell states at the top of human hematopoietic hierarchy","author":"Sommarin","year":"2  2021","journal-title":"bioRxiv"},{"issue":"5","key":"2026012911212142800_bib54","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-021-01238-w","article-title":"Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape","volume":"35","author":"Hsieh","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"2026012911212142800_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41375-023-02074-w","article-title":"Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation","volume":"38","author":"Huuhtanen","year":"2024","journal-title":"Leukemia"},{"issue":"4","key":"2026012911212142800_bib56","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/bloodadvances.2024014592","article-title":"Chronic inflammation deters natural killer cell fitness and cytotoxicity in myeloid leukemia","volume":"9","author":"Kuznetsova","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"2026012911212142800_bib57","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41467-024-45471-0","article-title":"Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche","volume":"15","author":"Dawson","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"2026012911212142800_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3324\/haematol.2019.232793","article-title":"The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission","volume":"106","author":"Jeanpierre","year":"2021","journal-title":"Haematologica"},{"issue":"11","key":"2026012911212142800_bib59","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/s41375-022-01682-2","article-title":"Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance","volume":"36","author":"B\u00fchrer","year":"2022","journal-title":"Leukemia"},{"issue":"17","key":"2026012911212142800_bib60","doi-asserted-by":"crossref","first-page":"e152585","DOI":"10.1172\/JCI152585","article-title":"IFN-alpha with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia","volume":"132","author":"Huuhtanen","year":"2022","journal-title":"J Clin Invest"},{"issue":"15","key":"2026012911212142800_bib61","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2024025286","article-title":"High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia","volume":"145","author":"Nygren","year":"2025","journal-title":"Blood"},{"issue":"9","key":"2026012911212142800_bib62","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.2024026310","article-title":"The evolution of treatment-free remission","volume":"145","author":"Hughes","year":"2025","journal-title":"Blood"},{"issue":"1","key":"2026012911212142800_bib63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2026012911212142800_bib64","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/leu.2010.185","article-title":"Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR","volume":"24","author":"Ross","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"2026012911212142800_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10238-025-01626-x","article-title":"Evaluation of leukemic stem cell (CD26 +) in chronic myeloid leukemia patients with different molecular responses and in treatment-free remission","volume":"25","author":"Camacho","year":"2025","journal-title":"Clin Exp Med"},{"issue":"6","key":"2026012911212142800_bib66","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/s41375-019-0684-5","article-title":"CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy","volume":"34","author":"Kinstrie","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"2026012911212142800_bib67","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41375-019-0647-x","article-title":"Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission","volume":"34","author":"Pagani","year":"2020","journal-title":"Leukemia"},{"issue":"25","key":"2026012911212142800_bib68","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.2023021119","article-title":"Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy","volume":"142","author":"Pagani","year":"2023","journal-title":"Blood"},{"issue":"suppl 1","key":"2026012911212142800_bib69","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood-2018-99-119267","article-title":"Multiparameter single cell analysis to identify immune cell states that may contribute to successful treatment discontinuation in patients with chronic myeloid leukemia","volume":"132","author":"Jang","year":"2018","journal-title":"Blood"},{"key":"2026012911212142800_bib70","doi-asserted-by":"crossref","first-page":"1117781","DOI":"10.3389\/fonc.2023.1117781","article-title":"Case report: long-term voluntary tyrosine kinase inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): molecular evidence of an immune surveillance","volume":"13","author":"Imeri","year":"2023","journal-title":"Front Oncol"},{"issue":"11","key":"2026012911212142800_bib71","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1080\/10428194.2022.2086243","article-title":"Single-cell RNA sequencing to explore composition of peripheral blood NK cells in patients with chronic myeloid leukemia in treatment-free remission","volume":"63","author":"Yu","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2026012911212142800_bib72","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood.2024026512","article-title":"How I approach hematopoietic stem cell transplantation for CML in a TKI world","volume":"147","author":"Chalandon","year":"2026","journal-title":"Blood"},{"issue":"6","key":"2026012911212142800_bib73","doi-asserted-by":"crossref","first-page":"109992","DOI":"10.1016\/j.celrep.2021.109992","article-title":"Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy","volume":"37","author":"Bachireddy","year":"2021","journal-title":"Cell Rep"},{"issue":"103","key":"2026012911212142800_bib74","doi-asserted-by":"crossref","first-page":"eadr0782","DOI":"10.1126\/sciimmunol.adr0782","article-title":"Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy","volume":"10","author":"Maurer","year":"2025","journal-title":"Sci Immunol"},{"key":"2026012911212142800_bib75","doi-asserted-by":"publisher","DOI":"10.1101\/2025.05.29.656798","article-title":"ASXL1 truncating mutations drive leukemic resistance to T cell attack","author":"McCurry","year":"12  2025","journal-title":"bioRxiv"},{"issue":"14","key":"2026012911212142800_bib76","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1016\/j.cell.2025.06.009","article-title":"A clinical road map for single-cell omics","volume":"188","author":"Skinnider","year":"2025","journal-title":"Cell"},{"issue":"2","key":"2026012911212142800_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41587-024-02138-x","article-title":"Can single-cell biology realize the promise of precision medicine?","volume":"42","author":"Sheridan","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"10","key":"2026012911212142800_bib78","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.cell.2024.03.009","article-title":"The future of rapid and automated single-cell data analysis using reference mapping","volume":"187","author":"Lotfollahi","year":"2024","journal-title":"Cell"},{"issue":"1","key":"2026012911212142800_bib79","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1038\/s41467-022-32097-3","article-title":"Scarf enables a highly memory-efficient analysis of large-scale single-cell genomics data","volume":"13","author":"Dhapola","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"2026012911212142800_bib80","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00018-022-04482-0","article-title":"Sample-multiplexing approaches for single-cell sequencing","volume":"79","author":"Zhang","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"2026012911212142800_bib81","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41592-018-0229-2","article-title":"Deep generative modeling for single-cell transcriptomics","volume":"15","author":"Lopez","year":"2018","journal-title":"Nat Methods"},{"issue":"2","key":"2026012911212142800_bib82","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bioinformatics\/btaa687","article-title":"Dream: powerful differential expression analysis for repeated measures designs","volume":"37","author":"Hoffman","year":"2021","journal-title":"Bioinformatics"},{"issue":"1","key":"2026012911212142800_bib83","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","article-title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells","volume":"10","author":"Kaya-Okur","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"2026012911212142800_bib84","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41467-020-14391-0","article-title":"Surface protein imputation from single cell transcriptomes by deep neural networks","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"2026012911212142800_bib85","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s42003-021-02135-9","article-title":"BABEL: using deep learning to translate between single-cell datasets","volume":"4","author":"Inglis","year":"2021","journal-title":"Commun Biol"},{"key":"2026012911212142800_bib86","doi-asserted-by":"publisher","DOI":"10.1101\/2025.11.06.686964","article-title":"Multi-agent AI enables evidence-based cell annotation in single-cell transcriptomics","author":"Ahuja","year":"7  2025","journal-title":"bioRxiv"},{"issue":"8","key":"2026012911212142800_bib87","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41592-024-02235-4","article-title":"Assessing GPT-4 for cell type annotation in single-cell RNA-seq analysis","volume":"21","author":"Hou","year":"2024","journal-title":"Nat Methods"},{"issue":"5","key":"2026012911212142800_bib88","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","article-title":"Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes","volume":"39","author":"Gao","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2026012911212142800_bib89","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes","volume":"15","author":"Efremova","year":"2020","journal-title":"Nat Protoc"},{"issue":"18","key":"2026012911212142800_bib90","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood.2024024761","article-title":"A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy","volume":"144","author":"Zhang","year":"2024","journal-title":"Blood"},{"issue":"5","key":"2026012911212142800_bib91","doi-asserted-by":"crossref","first-page":"bbad297","DOI":"10.1093\/bib\/bbad297","article-title":"Toward the functional interpretation of somatic structural variations: bulk- and single-cell approaches","volume":"24","author":"Yi","year":"2023","journal-title":"Brief Bioinform"},{"issue":"7","key":"2026012911212142800_bib92","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","article-title":"Lineage tracing meets single-cell omics: opportunities and challenges","volume":"21","author":"Wagner","year":"2020","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2026012911212142800_bib93","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.cell.2023.02.016","article-title":"A reference cell tree will serve science better than a reference cell atlas","volume":"186","author":"Domcke","year":"2023","journal-title":"Cell"},{"issue":"5","key":"2026012911212142800_bib94","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/genes11050549","article-title":"Single-cell RNA sequencing of hematopoietic stem and progenitor cells treated with gemcitabine and carboplatin","volume":"11","author":"Bj\u00f6rn","year":"2020","journal-title":"Genes (Basel)"},{"key":"2026012911212142800_bib95","doi-asserted-by":"crossref","first-page":"112212","DOI":"10.1016\/j.intimp.2024.112212","article-title":"Dynamic single-cell RNA-seq reveals mechanism of selinexor-resistance in chronic myeloid leukemia","volume":"134","author":"Cui","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"2026012911212142800_bib96","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3324\/haematol.2017.167080","article-title":"Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib","volume":"102","author":"Gullaksen","year":"2017","journal-title":"Haematologica"},{"issue":"7561","key":"2026012911212142800_bib97","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature14590","article-title":"Single-cell chromatin accessibility reveals principles of regulatory variation","volume":"523","author":"Buenrostro","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2026012911212142800_bib98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-016-1133-7","article-title":"Single-cell epigenomic variability reveals functional cancer heterogeneity","volume":"18","author":"Litzenburger","year":"2017","journal-title":"Genome Biol"},{"issue":"1","key":"2026012911212142800_bib99","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41467-018-07115-y","article-title":"Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity","volume":"9","author":"Chen","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"2026012911212142800_bib100","doi-asserted-by":"crossref","first-page":"eaav2249","DOI":"10.1126\/sciadv.aav2249","article-title":"Multiplexed single-cell RNA-seq via transient barcoding for simultaneous expression profiling of various drug perturbations","volume":"5","author":"Shin","year":"2019","journal-title":"Sci Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/5\/485\/2501322\/blood_bld-2025-029011-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/5\/485\/2501322\/blood_bld-2025-029011-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:21:36Z","timestamp":1769703696000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/5\/485\/547837\/Insights-from-single-cell-omics-cellular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,1,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025029011","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,29]]},"published":{"date-parts":[[2026,1,29]]}}}